Muscle fat infiltration assessed by total psoas density on computed tomography predicts mortality in cirrhosis
Author:
Open Access
- 1 January 2018
- journal article
- research article
- Published by Hellenic Society of Gastroenterology in Annals of Gastroenterology
- Vol. 31 (4) , 491-498
Abstract
Background Ongoing evidence suggests that sarcopenia adversely affects outcomes in cirrhosis. The aim of this study was to evaluate muscle fat infiltration as a component of sarcopenia and its prognostic value in this setting. Methods In 98 consecutive patients with cirrhosis, muscle density was measured during a computed tomography scan at the level of the fourth to fifth lumbar (L4) vertebrae. Univariate and multivariate Cox regression analysis was used to determine predictors of survival. Results Body mass index: median 26 (range 17-45.2); model for end-stage liver disease (MELD) score: median 11 (6-29); Child-Pugh (CP) score: median 7 (5-13), CP class: A=49 (50.5%), B=39 (40%), C=10 (9.5%); hepatocellular carcinoma: 14 (14.3%); follow up: median 45 (1-140) months. Median L4 total psoas area (TPA): 2022 (777-3806) mm(2); L4 average total psoas density (ATPD): 42.52 (21.26-59.8) HU. ATPD was significantly correlated with age (r=-0.222, P=0.034), creatinine (r=-0.41, P<0.001), albumin (r=0.224, P=0.035), MELD score (r=-0.218, P=0.034), and TPA (r=0.415, P<0.001). Fifty-four patients (55.1%) died during follow up. In the multivariate analysis, higher CP score (hazard ratio [HR] 1.2, 95% confidence interval [CI] 1.04-1.41), advanced age (HR 1.038, 95% CI 1.006-1.07) and lower ATPD (HR 0.967, 95% CI 0.937-0.997) were predictors of mortality. Conclusion Muscle fat infiltration, as a result of sarcopenia, is a negative predictive factor of survival in cirrhosis, emphasizing the need for early identification of this subgroup of patients.Keywords
This publication has 29 references indexed in Scilit:
- Cancer cachexia: impact, mechanisms and emerging treatmentsJournal of Cachexia, Sarcopenia and Muscle, 2012
- Consensus Statement: Academy of Nutrition and Dietetics and American Society for Parenteral and Enteral NutritionJournal of Parenteral and Enteral Nutrition, 2012
- Sarcopenia as a Prognostic Factor among Patients with Stage III MelanomaAnnals of Surgical Oncology, 2011
- Sarcopenia: An Undiagnosed Condition in Older Adults. Current Consensus Definition: Prevalence, Etiology, and Consequences. International Working Group on SarcopeniaJournal of the American Medical Directors Association, 2011
- Fat Infiltration of Muscle, Diabetes, and Clinical Fracture Risk in Older AdultsThe Journal of Clinical Endocrinology & Metabolism, 2010
- Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality riskLiver Transplantation, 2010
- Sarcopenia and Mortality after Liver TransplantationJournal of the American College of Surgeons, 2010
- Sarcopenia: European consensus on definition and diagnosisAge and Ageing, 2010
- Longitudinal study of muscle strength, quality, and adipose tissue infiltrationThe American Journal of Clinical Nutrition, 2009
- Excessive Adipose Tissue Infiltration in Skeletal Muscle in Individuals With Obesity, Diabetes Mellitus, and Peripheral Neuropathy: Association With Performance and FunctionPhysical Therapy, 2008